Schneider National (NYSE:SNDR – Get Free Report) is set to release its earnings data before the market opens on Wednesday, November 6th. Analysts expect Schneider National to post earnings of $0.23 per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.
Schneider National Trading Up 0.6 %
NYSE:SNDR opened at $28.57 on Tuesday. Schneider National has a 12 month low of $20.50 and a 12 month high of $29.18. The firm has a market cap of $5.01 billion, a price-to-earnings ratio of 43.95, a P/E/G ratio of 2.88 and a beta of 0.85. The company has a quick ratio of 1.46, a current ratio of 1.59 and a debt-to-equity ratio of 0.04. The company’s 50 day moving average is $27.67 and its 200-day moving average is $25.08.
Schneider National Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 8th. Stockholders of record on Friday, December 13th will be given a $0.095 dividend. This represents a $0.38 dividend on an annualized basis and a dividend yield of 1.33%. The ex-dividend date of this dividend is Friday, December 13th. Schneider National’s dividend payout ratio is 58.46%.
Analyst Upgrades and Downgrades
View Our Latest Stock Report on Schneider National
About Schneider National
Schneider National, Inc, together with its subsidiaries, provides surface transportation and logistics solutions in the United States, Canada, and Mexico. It operates through three segments: Truckload, Intermodal, and Logistics. The Truckload segment offers over the road freight transportation services primarily through dry van, bulk, temperature-controlled, and flat-bed trailers across either network or dedicated configurations.
Featured Stories
- Five stocks we like better than Schneider National
- What Are the U.K. Market Holidays? How to Invest and Trade
- Intel: Is Now the Time to Be Brave?
- Best Stocks Under $5.00
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Why Invest in 5G? How to Invest in 5G Stocks
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Schneider National Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schneider National and related companies with MarketBeat.com's FREE daily email newsletter.